Epirubicin and long-term heart failure risk in breast cancer survivors-Reference-Cited by-同舟云学术

Epirubicin and long-term heart failure risk in breast cancer survivors

Published:2018-07-04 Issue:10 Volume:20 Page:1454-1456
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Mahmood Syed S.¹,Patel Ravi B.²,Butler Javed³,Vaduganathan Muthiah⁴

Affiliation:

1. Division of Cardiology; New York Presbyterian Hospital-Weill Cornell Medical Center; New York NY USA

2. Division of Cardiology, Bluhm Cardiovascular Institute at Northwestern Memorial Hospital; Northwestern University Feinberg School of Medicine; Chicago IL USA

3. Department of Medicine; University of Mississippi; Jackson MS USA

4. Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School; Boston MA USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ejhf.1215/fullpdf

Reference14 articles.

1. Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level;Barac;J Am Coll Cardiol,2015

2. Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?;Levis;Lancet Oncol,2017

3. Cancer treatment and survivorship statistics, 2016;Miller;CA Cancer J Clin,2016

4. Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer;Basser;Ann Oncol,1999

5. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients;Ryberg;J Natl Cancer Inst,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective Effect of Statins on Cardiotoxicity Induced by Antitumor Drugs;Advances in Clinical Medicine;2024

2. Recent death early warning value of ECG changes in patients with NSCLC;Medicine;2023-11-17

3. Hazard-based risk grouping effectively stratifying breast cancer patients in post-irradiation long-term heart diseases: a population-based cohort study;Frontiers in Cardiovascular Medicine;2023-04-27

4. Epirubicin Alters DNA Methylation Profiles Related to Cardiotoxicity;Frontiers in Bioscience-Landmark;2022-06-01

5. Cancer Therapy-Related Cardiovascular Complications in Clinical Practice: Current Perspectives;Journal of Clinical Medicine;2021-04-13